Privi Speciality Chemicals Limited (BOM:530117)
India · Delayed Price · Currency is INR | Market Cap | 136.38B +3.1% |
| Revenue (ttm) | 27.53B +17.5% |
| Net Income | 3.73B +39.8% |
| EPS | 95.47 +39.7% |
| Shares Out | 39.06M |
| PE Ratio | 36.57 |
| Forward PE | 28.43 |
| Dividend | 10.00 (0.29%) |
| Ex-Dividend Date | Nov 4, 2026 |
| Volume | 4,570 |
| Open | 3,441.30 |
| Previous Close | 3,448.90 |
| Day's Range | 3,419.95 - 3,525.75 |
| 52-Week Range | 2,569.15 - 3,775.70 |
| Beta | 0.15 |
| Analysts | Strong Buy |
| Price Target | 4,213.67 (+20.69%) |
| Earnings Date | Oct 30, 2026 |
About BOM:530117
Privi Speciality Chemicals Limited, together with its subsidiaries, manufactures, supplies, and trades in aroma and fragrance chemicals in India and internationally. The company offers aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, ambery woody extreme, beta iso damascol, bi perfumery and technical grades, camphor, carene, carvacrol, cedar ketol, cineole, citronellal, citronellol, citronellyl acetate and nitrile, cyclademol, cyclamen aldehyde, dipentene, double distilled turpentine oi... [Read more]
Financial Performance
In fiscal year 2026, BOM:530117's revenue was 25.64 billion, an increase of 22.01% compared to the previous year's 21.01 billion. Earnings were 3.28 billion, an increase of 75.16%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for 530117 stock is "Strong Buy." The 12-month stock price target is ₹4,214, which is an increase of 20.69% from the latest price.
News
Privi Speciality Chemicals Transcript: Q2 26/27
Q2 FY27 set records for sales and profitability, with revenue up 13.9% and PAT up 24.61% YoY. Management maintained 20% growth guidance and expects expansion-led growth, while regulatory approvals remain a key execution dependency.
Privi Speciality Chemicals Quarterly report: Q2 2027
Privi Speciality Chemicals has published its Q2 2027 quarterly earnings report on October 30, 2026.
Privi Speciality Chemicals Slides: Q2 2027
Privi Speciality Chemicals has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on October 30, 2026.
Privi Speciality Chemicals Transcript: Q1 26/27
Q1 FY 2027 delivered 20% revenue growth and robust margins, driven by strong demand and operational efficiency. Capacity expansions and new specialty products are on track, with management reaffirming ambitious multi-year growth targets.
Privi Speciality Chemicals Quarterly report: Q1 2027
Privi Speciality Chemicals has published its Q1 2027 quarterly earnings report on July 31, 2026.
Privi Speciality Chemicals Slides: Q1 2027
Privi Speciality Chemicals has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 31, 2026.
Privi Speciality Chemicals Transcript: Q4 25/26
Revenue grew 21.7% and EBITDA 40.4% YoY in FY 2025-26, with margins at 25.8% and PAT up 75%. Capacity expansions, new specialty products, and a profitable JV drive a strong outlook, targeting 20% growth and sustained margins.
Privi Speciality Chemicals Quarterly report: Q4 2026
Privi Speciality Chemicals has published its Q4 2026 quarterly earnings report on May 12, 2026.
Privi Speciality Chemicals Slides: Q4 2026
Privi Speciality Chemicals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 12, 2026.
Privi Speciality Chemicals Annual report: Q4 2026
Privi Speciality Chemicals has published its Q4 2026 annual report on May 12, 2026.
Privi Speciality Chemicals Transcript: Q3 25/26
Reported 24% YoY revenue growth and 25%+ EBITDA margins for Q3 and nine months, with strong operational efficiency and robust export demand. Capacity expansion and new product launches are on track, targeting INR 5,000 crore revenue and INR 1,000 crore EBITDA in 3-4 years.
Privi Speciality Chemicals Quarterly report: Q3 2026
Privi Speciality Chemicals has published its Q3 2026 quarterly earnings report on February 10, 2026.
Privi Speciality Chemicals Slides: Q3 2026
Privi Speciality Chemicals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 10, 2026.
Privi Speciality Chemicals Transcript: Q2 25/26
Record Q2 and H1 FY2026 results with 26% YoY revenue growth and 59% YoY EBITDA growth, driven by flagship and new products, high capacity utilization, and strong demand across global and domestic markets. Capacity expansion and product diversification support a robust outlook.
Privi Speciality Chemicals Quarterly report: Q2 2026
Privi Speciality Chemicals has published its Q2 2026 quarterly earnings report on November 7, 2025.
Privi Speciality Chemicals Slides: Q2 2026
Privi Speciality Chemicals has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 7, 2025.